Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Eisai Enters Into Joint Development Agreement with Blissbio for Antibody Drug Conjugate BB-1701
Eisai announced today that it has entered into a joint development agreement with Bliss Biopharmaceutical […]
Henry Schein Acquires Regional Health Care Group, a Medical Distributor Serving the Australia and New Zealand Region
Henry Schein, the world’s largest provider of health care products and services to office-based dental […]
BeiGene Receives New Approvals for BRUKINSA (zanubrutinib) in China
BeiGene, a global biotechnology company, has announced the China National Medical Products Administration (NMPA) approved […]
CANbridge Pharmaceuticals Appoints Jason West Vice President, Head of Gene Therapy Research
CANbridge Pharmaceuticals, a global biopharmaceutical company, with a foundation in China, committed to the research, […]
Eli Lilly's Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer's Disease
Eli Lilly and Company have announced positive results of the TRAILBLAZER-ALZ 2 Phase 3 study […]
Senhwa Biosciences Received Taiwan FDA IND Approval for Phase II Study of Silmitasertib in Patients with Moderate to Severe COVID-19
Senhwa Biosciences, a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and […]
OliX Pharmaceuticals Announces Positive Results from a Phase 2a Trial of OLX10010 for Hypertrophic Scar Treatment
OliX Pharmaceuticals, a leading developer of RNAi therapeutics, today announced positive headline results of a […]
Gameto Expands Executive Team with the Addition of Teri Loxam as Chief Financial Officer
Gameto, a female-led biotech company developing therapies to improve the female reproductive journey, today announced […]
Ossium Health Awarded $3.46M in Funding from the California Institute of Regenerative Medicine
Ossium Health, announced today that the California Institute of Regenerative Medicine (CIRM) has awarded the […]
Alphyn Biologics Presents Pediatric Data from Atopic Dermatitis Trial at European Society for Pediatric Dermatology Congress
Alphyn Biologics, a clinical-stage dermatology company developing first-in-class multi-target therapeutics, will present for the first […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more